Epicutaneous Immunization with a dry patch formulation of SARS-CoV-2 S1

Project Details

Description

Objective: to demonstrate immunogenicity and efficacy of a dry-patch formulation of SARS-CoV-2 S1 applied to laser microporated skin
Short titleEPIMMUN SARS-CoV-2
AcronymEPIMMUN SARS-CoV-2
StatusActive
Effective start/end date18/05/20 → 31/12/20